Mark Mulvihill

USPTO Granted Patents = 2 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

2 out of 6

Guangzhou Innocare Pharma Tech Co., Ltd.

patents

Years Active: 2019-2022

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11345695 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2022-05-31),

2. 10301297 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2019-05-28),

Title: The Innovative Mind of Mark Mulvihill

Introduction: Mark Mulvihill, a talented inventor hailing from Sudbury, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Mark Mulvihill's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Mark Mulvihill has established himself as a visionary inventor. His work has been recognized with multiple awards, including the prestigious Innovation Award for Technology Advancement.

Collaborations: Throughout his career, Mark Mulvihill has collaborated with leading research institutions and universities to further develop his inventions. His partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Mark Mulvihill's passion for innovation and dedication to creating a positive impact on society continue to drive his success as an inventor. His relentless pursuit of excellence sets him apart as a true pioneer in the field of technology.

This text is generated by artificial intelligence and may not be accurate.